Add-on effect of Chinese herbal medicine in the treatment of mild to moderate COVID-19: A systematic review and meta-analysis

X Du, L Shi, W Cao, B Zuo, A Zhou - PLoS One, 2021 - journals.plos.org
mild to moderate COVID-19 accounts for the largest proportion of cases. It is of great importance
to treat such COVID-19 … in the treatment of mild to moderate COVID-19 was superior to …

[PDF][PDF] Outcome of ivermectin treated mild to moderate COVID-19 cases: a single-centre, open-label, randomised controlled study

CS Podder, N Chowdhury, MI Sina… - IMC Journal of …, 2020 - pdfs.semanticscholar.org
… 2 (SARS-CoV-2) infection based mostly on existing data from previous coronavirus … of
COVID-19. This study evaluated the outcome of ivermectin treated mild to moderate COVID-19

[HTML][HTML] Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study

Y Cen, X Chen, Y Shen, XH Zhang, Y Lei, C Xu… - Clinical Microbiology …, 2020 - Elsevier
mild or moderate COVID-19 at admission were consecutively recruited in the present study.
Cases of COVID-19 … The end point was conversion from mild or moderate stage to severe or …

Acute symptoms of mild to moderate COVID-19 are highly heterogeneous across individuals and over time

TL Rodebaugh, MR Frumkin… - Open forum …, 2021 - academic.oup.com
… The aim of the current study is to characterize the temporal dynamics of COVID-19 … ) for
early COVID-19 treatment [12]. Participants reported on their experience of common COVID-19

Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: a cohort …

J Tian, S Yan, H Wang, Y Zhang, Y Zheng, H Wu… - Pharmacological …, 2020 - Elsevier
mild and moderate coronavirus disease 2019 (COVID-19). … severe disease in mild and
moderate COVID-19 patients. We … of patients with mild and moderate COVID-19 in a quarantine …

Insight into pain syndromes in acute phase of mild‐to‐moderate COVID19: Frequency, clinical characteristics, and associated factors

E Oguz‐Akarsu, G Gullu, E Kilic, Y Dinc… - … Journal of Pain, 2022 - Wiley Online Library
… This study described the main pain syndromes associated acute phase of mild-to-moderate
COVID-19 and its associated features. Headaches and pain of neuropathic characteristics …

Considerations for return to exercise following mild-to-moderate COVID-19 in the recreational athlete

JD Metzl, K McElheny, JN Robinson, DA Scott… - HSS Journal …, 2020 - journals.sagepub.com
… Nevertheless, the morbidity from COVID-19 is significant and … return to exercise after
mild-to-moderate COVID-19, the wide … return to activity following mild to moderate COVID-19 in the …

Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19

RR Razonable, C Pawlowski, JC O'Horo, LL Arndt… - …, 2021 - thelancet.com
… with mild to moderate coronavirus disease-19 (COVID-19) is needed. This study aimed to
assess the outcomes of casirivimab–imdevimab treatment of mild to moderate COVID-19. …

Mild-to-moderate COVID-19 convalescents may present pro-longed Endothelium Injury

P Kozłowski, M Śmiarowski, W Przyborska… - Journal of clinical …, 2022 - mdpi.com
… The immune response towards coronavirus is also … and leukocyte adhesion and fibrin
formation [19]. The mechanisms briefly … The aim of this study was to evaluate whether COVID-19

[HTML][HTML] Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19

GU Kim, MJ Kim, SH Ra, J Lee, S Bae, J Jung… - Clinical microbiology …, 2020 - Elsevier
… isolation of patients without moderate-to-severe symptoms of COVID-19 in South Korea. …
mild COVID-19 were evaluated through a questionnaire-based survey. Diagnosis of COVID-19